海力特公司官网

SARS-CoV-2 (ORF1ab/N) Nucleic Acid Detection Kit (PCR-Fluorescent Probe)

     

    Product Information

    Intended Use

    Qualitative or quantitative detection of the ORF1ab and N genes of the SARS-CoV-2.

     

    Specifications

    48 tests/kit

    Specimen type

    Serum/Plasma, Whole blood, Nasopharyngeal/ Oropharyngeal swab, Anal swab, Sputum, Tracheal Aspirate, Broncheo ,Alveolar Lavage (BAL) fluid, Pleural fluid and Urine.

    Sensitivity

    10 copies/PCR

    Precision

    Within / between batches CV < 5%

    Expiration Date

    The kit is best used within 12 months from manufacturing ,please stored at – 20 ± 5 ℃.

    Specificity

    No Cross-activity detected with other coronavirus (SARS, MERS, OC43, NL63, 229E and HKU1), influenza virus (H1N1, H3N2 and B), respiratory syncytial virus (RSV long strain), adenovirus, metapneumovirus, mycobacterium tuberculosis, bordetella pertussis, staphylococcus aureus, mycoplasma pneumoniae and chlamydia pneumoniae

    Instrument

    ABI 7500 Real-Time PCR Systems, ABI QuantStudioTM Dx Real-Time PCR Systems and ABI ViiA 7 Dx Real-Time PCR Systems and SLAN-96 Real-Time PCR Systems.

     

    Product Advantages

    Higher sensitivity, crack "false negative" (can detect asymptomatic people)

    ·All 27 cases of 2019-nCoV infection were confirmed;

    ·Among the 50 pharyngeal test specimens or nasopharyngeal swab samples suspected of 2019-nCoV infection, the detection rate increased by 33.3% compared with the approved marketed products (follow the table below);;

    image.png 

    ※ Seven more suspected patients detected by SUPBIO than other products, these patients were confirmed to be infected by the SARS-CoV-2.

     

    High specificity

    检测Detected 6000 healthy people and excluded patients with SARS-CoV-2 infection, all were not detected;

     

    Quantitative detection

    The kit contains quantitative reference products to provide quantitative indicators for scientific or clinical research;

     

    Add internal standard and monitor the whole process

    Add endogenous internal standard to monitor sample collection, nucleic acid extraction and amplification process to avoid false negative results [3];

     

    Multi-scenario application

    There are various types of testable specimens to meet the needs of a variety of clinical scenarios, increase the sampling of different parts of the same patient, reduce the "false negative" results [3]

    A variety of nucleic acid extraction and PCR instrument can be applied to facilitate laboratories in various medical institutions to carry out new coronavirus detection projects;

    It can be used for incubation crowds, returning to cities and returning to work, medical examinations for employees of enterprises, and screening for students returning to school, to stop the spread of the epidemic in time, and to help resume work and resume production.

     

    reference

    [1] WHO. Coronavirus disease (COVID-19) outbreak [EB/OL]. [2020-02-18]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019

    [2] 中华医学会检验医学分会. 新型冠状病毒肺炎病毒核酸检测专家共识 [J] . 中华医学杂志,2020,100( 00 ): E003-E003.

    [3] 莫茜, 秦炜, 傅启华, 等.  正确认识新冠病毒核酸检测的影响因素 [J] . 中华检验医学杂志,2020,43( 00 ): E002-E002.


更多产品
合作单位